The Exeter has added its Real Life product to IPipeline’s Advanced Underwriting adviser platform.
The platform launched in September and captures upfront information to assess the top 20 most common medical disclosures. These typically represent up to 80% of all medical loadings and changes in terms, post-application.
The Exeter joins Vitality and Zurich in using the new platform with three other companies set to join the platform soon, IPipeline said.
Jack Southcott, head of protection proposition at The Exeter, said he was pleased with the move and saw it as a big step forward in how the insurer supported advisers and their clients.
Rachel Edwards, managing director UK of IPipeline, (pictured) said the firm was delighted with the agreement.
